201 related articles for article (PubMed ID: 24965710)
21. IL-10 plays a central regulatory role in the cytokines induced by hepatitis C virus core protein and polyinosinic acid:polycytodylic acid.
Pang X; Wang Z; Zhai N; Zhang Q; Song H; Zhang Y; Li T; Li H; Su L; Niu J; Tu Z
Int Immunopharmacol; 2016 Sep; 38():284-90. PubMed ID: 27337528
[TBL] [Abstract][Full Text] [Related]
22. Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon.
Cicinnati VR; Kang J; Sotiropoulos GC; Hilgard P; Frilling A; Broelsch CE; Gerken G; Beckebaum S
J Gen Virol; 2008 May; 89(Pt 5):1243-1253. PubMed ID: 18420803
[TBL] [Abstract][Full Text] [Related]
23. HCV core protein binds to gC1qR to induce A20 expression and inhibit cytokine production through MAPKs and NF-κB signaling pathways.
Song X; Yao Z; Yang J; Zhang Z; Deng Y; Li M; Ma C; Yang L; Gao X; Li W; Liu J; Wei L
Oncotarget; 2016 Jun; 7(23):33796-808. PubMed ID: 27183919
[TBL] [Abstract][Full Text] [Related]
24. Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients.
Rodrigue-Gervais IG; Jouan L; Beaulé G; Sauvé D; Bruneau J; Willems B; Sékaly RP; Lamarre D
J Virol; 2007 Jun; 81(11):5537-46. PubMed ID: 17376921
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma.
Han TH; Jin P; Ren J; Slezak S; Marincola FM; Stroncek DF
J Immunother; 2009 May; 32(4):399-407. PubMed ID: 19342965
[TBL] [Abstract][Full Text] [Related]
26. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
27. Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin.
Perrella A; Sbreglia C; Atripaldi L; Esposito C; D'Antonio A; Perrella O
Scand J Gastroenterol; 2010; 45(2):250-5. PubMed ID: 19968615
[TBL] [Abstract][Full Text] [Related]
28. Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.
Huang Y; Feld JJ; Sapp RK; Nanda S; Lin JH; Blatt LM; Fried MW; Murthy K; Liang TJ
Gastroenterology; 2007 Feb; 132(2):733-44. PubMed ID: 17258724
[TBL] [Abstract][Full Text] [Related]
29. KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C.
Umemura T; Ota M; Katsuyama Y; Wada S; Mori H; Maruyama A; Shibata S; Nozawa Y; Kimura T; Morita S; Joshita S; Komatsu M; Matsumoto A; Kamijo A; Kobayashi M; Takamatsu M; Yoshizawa K; Kiyosawa K; Tanaka E
Hum Immunol; 2014 Aug; 75(8):822-6. PubMed ID: 24929144
[TBL] [Abstract][Full Text] [Related]
30. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
[TBL] [Abstract][Full Text] [Related]
31. Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.
Díaz-Valdés N; Manterola L; Belsúe V; Riezu-Boj JI; Larrea E; Echeverria I; Llópiz D; López-Sagaseta J; Lerat H; Pawlotsky JM; Prieto J; Lasarte JJ; Borrás-Cuesta F; Sarobe P
Hepatology; 2011 Jan; 53(1):23-31. PubMed ID: 21154952
[TBL] [Abstract][Full Text] [Related]
32. Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up.
Knolle PA; Kremp S; Höhler T; Krummenauer F; Schirmacher P; Gerken G
J Viral Hepat; 1998 Nov; 5(6):399-406. PubMed ID: 9857349
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of A20/ABIN1 contributes to inefficient M1 macrophage polarization during Hepatitis C virus infection.
Fan C; Zhang Y; Zhou Y; Li B; He Y; Guo Y; Jia Z
Virol J; 2015 Sep; 12():147. PubMed ID: 26382585
[TBL] [Abstract][Full Text] [Related]
34. Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline.
Conry SJ; Meng Q; Hardy G; Yonkers NL; Sugalski JM; Hirsch A; Davitkov P; Compan A; Falck-Ytter Y; Blanton RE; Rodriguez B; Harding CV; Anthony DD
J Infect Dis; 2012 Apr; 205(7):1131-41. PubMed ID: 22351942
[TBL] [Abstract][Full Text] [Related]
35. Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.
Miyagi T; Takehara T; Nishio K; Shimizu S; Kohga K; Li W; Tatsumi T; Hiramatsu N; Kanto T; Hayashi N
J Hepatol; 2010 Sep; 53(3):424-30. PubMed ID: 20554341
[TBL] [Abstract][Full Text] [Related]
36. Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection.
Goutagny N; Vieux C; Decullier E; Ligeoix B; Epstein A; Trepo C; Couzigou P; Inchauspe G; Bain C
J Infect Dis; 2004 May; 189(9):1646-55. PubMed ID: 15116301
[TBL] [Abstract][Full Text] [Related]
37. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
[TBL] [Abstract][Full Text] [Related]
38. Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy.
Tsubouchi E; Akbar SM; Murakami H; Horiike N; Onji M
Clin Exp Immunol; 2004 Aug; 137(2):417-23. PubMed ID: 15270861
[TBL] [Abstract][Full Text] [Related]
39. Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes.
Mengshol JA; Golden-Mason L; Castelblanco N; Im KA; Dillon SM; Wilson CC; Rosen HR;
Gut; 2009 Jul; 58(7):964-73. PubMed ID: 19193669
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus load and expression of a unique subset of cellular genes in circulating lymphoid cells differentiate non-responders from responders to pegylated interferon alpha-ribavirin treatment.
Pham TN; Lin DM; Mulrooney-Cousins PM; Churchill ND; Kowala-Piaskowska A; Mozer-Lisewska I; Machaj A; Pazgan-Simon M; Zalewska M; Simon K; King D; Reddy SB; Michalak TI
J Med Virol; 2013 Mar; 85(3):441-8. PubMed ID: 23280583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
